Nolpaza - synthetic anti-ulcer medication used for the treatment of gastric and duodenal ulcers.
Nolpaza has antiulcer action, reducing acid secretion irrespective of the nature of the stimulus. The effect of the drug develops within hours and reaches a maximum after an average of two hours. In the opinion of Nolpaza well tolerated and does not affect the motility of the gastrointestinal tract.
The drug is released in the form of oval tan tablets, enteric-coated. Each tablet contains 20 mg (Nolpaza 20) or 40 mg (40 Nolpaza) pantoprazole, and 14 pieces in a blister pack. Excipients - crospovidone, mannitol, sodium carbonate anhydrous, calcium stearate and sorbitol.
According to the instructions Nolpazu used to treat:
- Gastroesophageal reflux disease including heartburn, regurgitation sour and pain when swallowing;
- Eradication of Helicobacter pylori, in a combination therapy with two antibiotics;
- Gastric ulcer and duodenal ulcer;
- Erosive and ulcerative lesions of the stomach and duodenum, which are associated with the use of nonsteroidal anti-inflammatory drugs;
- Zollinger-Ellison Syndrome or other pathological conditions related to increased gastric secretion.
Nolpazu contraindicated for instructions used in dyspepsia neurotic genesis, as well as in case of hypersensitivity to the active substance - pantoprazole or other components of the drug.
The drug is not used up to 18 years, and during pregnancy and lactation Nolpazu prescribed only under strict indications.
Before you start the application Nolpazy to rule out malignancy, as treatment may delay the diagnosis.
Instructions for use Nolpazy
Nolpazu according to the instructions advised to take before breakfast, or at double reception before breakfast and dinner.
When heartburn, regurgitation, sour and pain when swallowing in mild, the recommended dose - 1 tablet Nolpazy 20 per day, with more severe disease - 40-80 mg per day. Relief of symptoms after application Nolpazy usually occurs after two weeks, the optimal course of treatment - up to two months. For prevention of prolonged use and in maintenance therapy prescribed 1 tablet per day Nolpazy 20, if necessary dose can be increased twice.
It is also possible to take a one-time Nolpazu in case of symptoms of dyspepsia.
When erosive and ulcerative lesions of the stomach and duodenum caused by the use of nonsteroidal anti-inflammatory drugs, usually prescribed 1-2 tablets Nolpazy 40, for the prevention of taking 20 mg of the drug per day, with a course of treatment is usually at least a month.
For Helicobacter pylori eradication used combination therapy with antibiotics. Treatment usually lasts from one to two weeks. The drug is administered twice a day, 1 tablet Nolpazy 40.
When Zollinger-Ellison syndrome, and other pathological conditions related to increased gastric secretion, is recommended to take 80 mg of the drug per day, divided into two stages. Duration of therapy in this case is adjusted individually.
If abnormal liver function, as well as in the elderly Nolpazy daily dose of instructions must not exceed 40
In the absence of a therapeutic effect in a month of therapy it is recommended to confirm the diagnosis.
If necessary, you can use Nolpazy counterparts. The most common include enteric coated tablets Zipantola, Krosatsid, Kontrolok, Pantazi, Peptazol, Sanpraz, Puloref and others. In addition to drugs containing the same active ingredient, you can pick up other drugs proyazvennogo series. By this analogy Nolpazy include Pariet, Rabimak containing rabeprazole, Nexium containing esomeprazole, Ultop, Omez, Omizak Gastrozol containing omeprazole Akrilanz, Lanzap Epicurus containing lansoprazole, and others. Before using the analog Nolpazy should consult a doctor.
According to reviews Nolpaza often causes abdominal pain, diarrhea or constipation, flatulence, nausea and vomiting, dry mouth and headache.
Much less often while taking the drug may develop arthralgia, dizziness, blurred vision, itching, or rash.
Nolpaza on responses rarely causes: increase in liver transaminases, severe liver disease, leukopenia and thrombocytopenia, peripheral edema, anaphylactic reactions, including anaphylactic shock, myalgia, painful tension of the mammary glands, depression, interstitial nephritis, Stevens-Johnson syndrome, urticaria, angioedema swelling, erythema multiforme, or Lyell's syndrome, photosensitivity, pyrexia, fatigue, elevated triglycerides.
In case of adverse effects of heavy drug treatment should be discontinued.
Nolpaza - drug prescription shelf life - up to 3 years.